Top story

U.S. FDA Grants Priority Review to Sonrotoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma

SAN CARLOS, Calif.--(BUSINESS WIRE) November 26, 2025 -- BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has accepted and …

Read full story

U.S. FDA Grants Priority Review to Sonrotoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma

Drugs.com - Clinical Trial Results
Wed, 26 Nov 2025
Read more

Novartis Ianalumab First Drug to Reduce Disease Activity and Patient Burden in Sjögren’s Disease Phase III Trials

Drugs.com - Clinical Trial Results
Wed, 29 Oct 2025
Read more

Sanofi’s Efdoralprin Alfa Met All Primary and Key Secondary Endpoints in Alpha-1 Antitrypsin Deficiency Emphysema Phase 2 Study

Drugs.com - Clinical Trial Results
Wed, 22 Oct 2025
Read more

Celcuity to Initiate NDA Submission of Gedatolisib in PIK3CA Wild-Type Cohort in HR+/HER2- Advanced Breast Cancer Under FDA’s Real-Time Oncology Review Program

Drugs.com - Clinical Trial Results
Wed, 27 Aug 2025
Read more

Sanofi’s SAR446523, a GPRC5D Monoclonal Antibody, Earns Orphan Drug Designation in the US for Multiple Myeloma

Drugs.com - Clinical Trial Results
Wed, 30 Jul 2025
Read more

Revolution Medicines Announces FDA Breakthrough Therapy Designation for Elironrasib

Drugs.com - Clinical Trial Results
Wed, 23 Jul 2025
Read more

Avidity Biosciences Receives FDA Breakthrough Therapy Designation for Delpacibart Zotadirsen (del-zota) for the Treatment of DMD in People with Mutations Amenable to Exon 44 Skipping

Drugs.com - Clinical Trial Results
Wed, 23 Jul 2025
Read more

Apnimed Reports Positive Topline Results from Second Phase 3 Trial of AD109, Reinforcing Potential of First Oral Pill for Obstructive Sleep Apnea

Drugs.com - Clinical Trial Results
Wed, 23 Jul 2025
Read more

Riliprubart Earns Orphan Drug Designation in the US for Antibody-Mediated Rejection in Solid Organ Transplantation

Drugs.com - Clinical Trial Results
Wed, 25 Jun 2025
Read more